DONDI, DONATELLA
 Distribuzione geografica
Continente #
EU - Europa 4.834
NA - Nord America 3.066
AS - Asia 2.179
SA - Sud America 201
AF - Africa 30
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.323
Nazione #
US - Stati Uniti d'America 2.983
GB - Regno Unito 1.954
DE - Germania 841
CN - Cina 791
SE - Svezia 517
SG - Singapore 515
IT - Italia 352
RU - Federazione Russa 264
HK - Hong Kong 229
NL - Olanda 214
TR - Turchia 206
UA - Ucraina 161
KR - Corea 158
FR - Francia 145
BR - Brasile 136
IE - Irlanda 132
EU - Europa 102
FI - Finlandia 101
IN - India 90
CA - Canada 52
CO - Colombia 36
PH - Filippine 31
GR - Grecia 29
VN - Vietnam 25
ID - Indonesia 23
BD - Bangladesh 19
BE - Belgio 17
JP - Giappone 17
ES - Italia 15
MX - Messico 15
DK - Danimarca 14
PL - Polonia 13
RO - Romania 13
IQ - Iraq 12
AU - Australia 9
IL - Israele 9
TW - Taiwan 9
UY - Uruguay 9
AT - Austria 8
CH - Svizzera 8
CL - Cile 7
NO - Norvegia 7
ZA - Sudafrica 7
ET - Etiopia 6
PK - Pakistan 6
PT - Portogallo 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
HR - Croazia 5
RS - Serbia 5
SA - Arabia Saudita 5
HU - Ungheria 4
JM - Giamaica 4
AR - Argentina 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
PA - Panama 3
SN - Senegal 3
VE - Venezuela 3
AO - Angola 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
IR - Iran 2
LK - Sri Lanka 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PE - Perù 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CI - Costa d'Avorio 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PY - Paraguay 1
SI - Slovenia 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 10.422
Città #
Southend 1.847
Hanover 379
Chandler 349
Seattle 271
Singapore 256
Hong Kong 224
Princeton 171
Ashburn 151
Milan 148
Beijing 142
Wilmington 141
Dublin 130
Redmond 126
Jacksonville 116
Ann Arbor 113
Council Bluffs 110
Woodbridge 97
Fairfield 92
Nanjing 80
Sakarya 78
Santa Clara 74
New York 70
Frankfurt am Main 67
Mountain View 67
Des Moines 66
Munich 57
Dearborn 55
Boardman 52
Houston 49
Somerville 42
Shenyang 41
Toronto 41
Andover 40
Cambridge 37
Shanghai 36
Bogotá 35
Jinan 32
Athens 29
Bengaluru 29
Los Angeles 28
Grafing 26
Norwalk 26
Cangzhou 25
Zhengzhou 25
Redwood City 24
Nanchang 23
Serra 23
Changsha 22
Bitonto 21
Mannheim 20
Medford 20
The Dalles 20
Columbus 18
Hangzhou 18
Guangzhou 17
Lanzhou 17
San Diego 17
Helsinki 16
Tianjin 16
Berlin 15
Brussels 15
Kiez 15
Ningbo 15
São Paulo 15
Hebei 14
Jiaxing 14
Fuzhou 12
Jakarta 12
Phoenix 12
Roxbury 12
Turin 12
Haikou 11
Tokyo 11
London 10
Sunnyvale 10
Taizhou 10
Auburn Hills 9
Istanbul 9
Rome 9
Warsaw 8
Belo Horizonte 7
Montevideo 7
Nürnberg 7
Oslo 7
New Delhi 6
Paris 6
Eitensheim 5
Falls Church 5
Quanzhou 5
Roubaix 5
Tashkent 5
Addis Ababa 4
Amsterdam 4
Baghdad 4
Belgrade 4
Brasília 4
Cape Town 4
Chengdu 4
Dallas 4
Dhaka 4
Totale 6.713
Nome #
The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway 388
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion 260
Antiproliferative effect of mifepristone ({RU}486) on human neuroblastoma cells ({SK}-N-{SH}): in vitro and in vivo studies 255
Expression and differential effects of the activation of glucocorticoid receptors in mouse gonadotropin-releasing hormone neurons 230
Estrogen receptor β and the progression of prostate cancer : role of 5{alpha}-androstane-3β,17β-diol 220
Biologia Cellulare 217
Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells 207
Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop 193
Effects of caloric restriction and low glycemic index diets associated with metformin on glucose metabolism and cortisol response in overweight/obese subjects: a case series study 169
Ageing of the neuroendocrine system in the brain of male rats: receptor mechanisms and steroid metabolism 166
Estrogen receptor beta and the progression of prostate cancer - role of 5alpha-androstane-3beta,17beta-diol (3beta-Adiol) 164
Aging and the hypothalamo-pituitary-testicular axis in the rat 157
Role of glucocorticoids in the migration of immature LHRH neurons 154
Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor 145
Role of estrogen receptor beta in the progression of prostate cancer 145
Effect of oestrus cyclicity on the number of brain opioid mu receptors in the rat 145
Binding characteristics of hypothalamic mu opioid receptors throughout the estrous cycle in the rat 143
Dexamethasone modulates differentiation and motility of SK-N-SH human neuroblastoma cells 141
Antiproliferative action of melatonin on human prostate cancer LNCaP cells 141
Regolazione del sistema attivatore del plasminogeno da parte degli ormoni glucocorticoidi nella progressione metastatica del cancro prostatico 139
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP 139
Role of Estrogen Receptor beta on prostate cancer cell migration 138
Role of Ozarelix in the control of proliferation, migration and invasion of human prostate cancer cell lines 137
Hypothalamic ß-endorphin and brain mu opiate receptor concentrations in male rat after restraint stress 137
Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH 137
Antiproliferative action of RU486 on human neuroblastoma cells (SK-N-SH) 135
Effects of aging on pituitary and testicular luteinizing hormone-releasing hormone receptors in the rat 134
Cellular mechanisms regulating uPA in hormone refractory prostate cancer : role of suPAR, a solubile form of Urokinase Plasminogen-Activator Receptor 133
Characterization of a soluble LHRH-degrading activity in the rat ventral prostate 133
Endocrinology of aging 132
Dexamethasone blocks the migration of the human neuroblastoma cell line SK-N-SH 132
Role of a soluble form of urokinase plasminogen-activator receptor in the control of human prostate cancer cell growth and invasion 131
Expression and role of glucocorticoid receptors in mouse neurons secretine gonadotropin releasing hormons 131
Endocrine responses to naloxone in young and old male rats. 130
Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 1141-1148 129
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system 127
In vivo growth properties and molecular marker expression of DU145 human prostate tumor cells expressing recombinant androgen receptor 127
Gonadal steroid modulation of brain opioid systems 125
Effect of aging on opioid and LHRH receptors in the brain, pituitary, and testis of the male rat 125
Role of estrogen receptor β in the pathogenesis and progression of prostate cancer 122
Decrease of mu opioid receptors in the brain and in the hypothalamus of the aged male rat 122
Involvment of the glucocorticoid receptor in the migration of GN11 LHRH neurons 121
Dexamethasone blocks the migration of the human neuroblastoma cell line SK-N-SH 121
Involvment of Glucocorticoid receptors in the migratore activity of immortalized GnRH secreting neurons 120
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors 119
Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth 117
Binding characteristics of delta opioid receptors in different regions of the brain of young and old male rats as studied with the highly selective ligand [D-Pen2-D-Pen5] enkephalin 116
Modulation by sex steroids of brain opioid receptors: implications for the control of gonadotropins and prolactin secretion 116
Growth factors in steroid-responsive prostatic tumor cells 116
Effect of LHRH analogs on the Urokinase Receptor in the metastatic progression of prostate cancer 114
The EGF/TGFalpha system as an autocrine growth stimulatory loop in LNCaP cells 114
Distribution of kappa opioid receptors in the brain of young and old male rats 113
Meccanismo d'azione degli ormoni 112
Effect of glucocorticoids on the plasminogen activator system in the metastatic progression of prostate cancer 111
Peptide-steroid interactions in the modulation of the hypothalamic-pituitary axis 111
Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors 111
LRHR as a growth-inhibitory factor in prostatic tumor cells: possible mechanism of action 110
Testosterone and postnatal ontogenesis of hypothalamic mu ([3H]dihydromorphine) opioid receptors in the rat 109
Morphine stimulates prolactin release in normal but not in castrated male rats 108
Hypothalamic opiatergic tone during pregnancy, parturition and lactation in the rat 108
Expression and role of functional glucocorticoid receptors in the human androgen-independent prostate cancer cell line, DU145 107
Soluble urokinase-type plasminogen activation receptor inhibits prostate cancer cell growth and invasion 106
Further evidence that gonadal steroids do not modulate brain opiate receptors in male rats 106
Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145 106
Effetto degli analoghi del GnRH sul sistema attivatore del plasminogeno nella progressione metastatica del cancro prostatico umano 105
Sex steroids and brain opioid receptors 105
Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice 104
La progressione metastatica del cancro prostatico umano: effetto degli analoghi del GnRH sul sistema attivatore del plasminogeno 103
GnRH analogues inhibit the plasminogen activator system and the metastatic progression of prostate cancer 101
The metastatic progression of prostate cancer : effect of LHRH analogs on plasminogen activator system 98
Epigenetic control of pi3k/akt activity in prostate cancer during hormone manipulation 98
The metastatic progression of prostate cancer effect of LHRH analogs on plasminogen activator system 96
Role of GnRH analogs in the control of the plasminogen activator system in human prostate cancer cell lines 96
Neonatal organization of the brain opioid systems controlling prolactin and luteinizing hormone secretion 96
Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP 95
Effect of ovarian steroids on the concentration of mu opiate receptors in different regions of the brain of the female rat 94
Dosimetric analysis of phenolic solid state pellets exposed to radio-therapeutic photon and electron beams through electron spin resonance technique=Analisi dosimetrica di composti fenolici irradiati con fasci clinici di fotoni ed elettroni tramite spettroscopia di risonanza di spin elettronico 94
Modulation of the binding characteristics of hypothalamic mu opioid receptors in rats by gonadal steroids 93
Effetto degli analoghi dell’LHRH sul sistema attivatore del plasminogeno nella progressione metastatica del cancro prostatico umano” 90
Effects of steroids on the brain opioid system 86
Biology of hypothalamic neurons producing gonadotropin-releasing hormone (GnRH): new information on the use of immortalized cells secreting GnRH 84
Mechanism of action of interleukin-1 in modulating gonadotropin secretion. In vivo and in vitro studies 78
Effects of ovarian hormones on brain opioid binding sites in castrated female rats 71
Totale 10.914
Categoria #
all - tutte 27.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.192 13 61 117 43 161 97 47 41 137 88 289 98
2021/20221.276 77 19 121 60 104 67 73 88 214 112 140 201
2022/20231.173 138 85 96 142 146 234 28 123 90 7 72 12
2023/2024686 25 62 35 41 201 44 25 32 5 11 102 103
2024/20251.694 55 101 15 149 172 75 49 187 81 198 114 498
2025/2026141 141 0 0 0 0 0 0 0 0 0 0 0
Totale 10.914